Results 51 to 60 of about 3,138,708 (171)
Mace‐Like Plasmonic Au‐Pd Heterostructures Boost Near‐Infrared Photoimmunotherapy
Photoimmunotherapy, with spatiotemporal precision and noninvasive property, has provided a novel targeted therapeutic strategy for highly malignant triple‐negative breast cancer (TNBC).
Yanlin Feng +10 more
doaj +1 more source
Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy. [PDF]
Abstract IL15 is a potent inducer of differentiation and proliferation of CD8+ T and natural killer (NK) cells, making it a promising candidate for cancer immunotherapy. However, limited efficacy of systemic monotherapy utilizing intravenous IL15 suggests the needs for alternative routes of administration or combination treatment with
Fukushima H +7 more
europepmc +3 more sources
Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44-targeting antibody-photoabsorber conjugates. [PDF]
Adachi Y., Miyake K., Ohira K., et al. Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44–targeting antibody–photoabsorber conjugates.
Adachi Y +15 more
europepmc +2 more sources
Near infrared photoimmunotherapy (NIR-PIT) is a newly developed molecular targeted cancer treatment, which selectively kills cancer cells or immune-regulatory cells and induces therapeutic host immune responses by administrating a cancer targeting moiety
Marwah Al-Rawe +13 more
core +1 more source
Near-infrared photoimmunotherapy (NIR-PIT) is a promising cancer therapy based on a monoclonal antibody conjugated to a photosensitizer (IR700Dye) that is activated by near-infrared light irradiation.
Yasuo Okada +6 more
core +1 more source
Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases
The bones are a common site for metastasis arising from solid tumors such as breast and prostate cancer. Chemotherapy, including immunotherapy, is rarely curative. Radiotherapy with pain palliation can temporize bone metastases but is generally considered a short-term solution and retreatment is difficult. Surgery is often necessary, yet recovery times
Fuyuki F, Inagaki +10 more
openaire +2 more sources
HER2 targeting near‐infrared photoimmunotherapy for a CDDP‐resistant small‐cell lung cancer
Background Human epidermal growth factor receptor 2 (HER2) is tyrosine kinase receptor that belongs to the ErbB family and is overexpressed on the membrane surface of various cancer cells, including small cell lung cancer (SCLC); however, no HER2 ...
Kazuomi Takahashi +8 more
doaj +1 more source
Near-Infrared Photoimmunotherapy for Treatment of Colorectal Cancer in Orthotopic Nude-Mouse Models
Background: Photoimmunotherapy (PIT) employs the use of near-infrared (NIR) laser to activate an antibody conjugated to a NIR-activatable dye to promote cancer cell death. PIT has shown to be effective in a number of studies, however, there is no data on
Filemoni Filemoni (8649674) +6 more
core +1 more source
Cancer has been threatening the safety of human life. In order to treat cancer, many methods have been developed to treat tumor, such as traditional therapies like surgery, chemotherapy, radiotherapy, as well as new strategies like photodynamic therapy ...
Weilin Chen +3 more
doaj +1 more source
Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy
Summary: Circulating drugs in the peritoneal cavity is an effective strategy for advanced ovarian cancer treatment. Photoimmunotherapy, an emerging modality with potential for the treatment of ovarian cancer, involves near-infrared light activation of ...
Aaron J. Sorrin +9 more
doaj +1 more source

